Pulsenmore Ltd. (PLSM) Fair Value 2026

PLSM · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.6 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (10/100)

Quick Summary — As of 2026-10-07, Pulsenmore Ltd. (PLSM) trades at $2.16, versus a $4.84 median fair value across its 2 active models — 124.1% above the current price. QOC: 5.6/10. Value Trap Risk: 10/100 (SAFE). 2/13 models active.

Key Facts

Ticker
PLSM
Price
$2.16
Quality Score
5.6/10
Value Trap Risk
10/100
Models Active
2/13
Last Updated
Strength: FTNN Topology suggests +223.1% upside with 6% confidence
Risk: Limited model coverage (2/13) may reduce confidence

Is Pulsenmore Ltd. (PLSM) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Pulsenmore Ltd. (PLSM) appears undervalued as of : the median of 2 independent fair value estimates is $4.84, 124.1% above the current price of $2.16. Estimates range from $2.70 to $6.98. PLSM scores 5.6/10 on fundamental quality and 10/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. PLSM’s +124.1% gap is wider than that market norm, and the Medical Devices sector median is -41.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Pulsenmore Ltd. Stock in 2026? →

What Fair Value Does Each Model Give PLSM?

2 Intrinsic Value Models vs. Current Price ($2.16)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · Medium Conviction
 $2.70 +25.1%
Relative · Low Conviction
 $6.98 +223.1%

All Models Active

All 2 models are displayed above.

What Is Pulsenmore Ltd. (PLSM) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Pulsenmore Ltd.'s intrinsic value is estimated at a median fair value of $4.84. At a current market price of $2.16, 2 of 2 active valuation models identify upside potential, projecting a median implied return of +124.1%. Notably, FTNN sees the most upside at +223.1% (fair value: $6.98), while Dynamic NAV is the most conservative at +25.1% ($2.70). The spread between these extremes — +198.0% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About PLSM?

2 of 13 models are currently active for PLSM. All 2 active models suggest the stock trades below fair value. Taken together, their median fair value for PLSM is $4.84 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does PLSM Rank in Medical Devices?

Among 161 Medical Devices stocks, PLSM ranks #114 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

The Medical Devices sector introduces analytical considerations specific to healthcare company businesses. For Pulsenmore Ltd., metrics like revenue per drug provide important context that general-purpose valuation models may underweight.

Is PLSM a Value Trap?

CirclFi's Value Trap algorithm assigns PLSM a score of 10/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Pulsenmore Ltd.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Pulsenmore Ltd. scores 5.6 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +198.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PLSM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across PLSM's 2 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Pulsenmore Ltd. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

NXLNexalin Technology, Inc.QOC 5.6LUCDLucid Diagnostics Inc.QOC 5.5NNOXNano-X Imaging Ltd.QOC 5.6GTHPGuided Therapeutics, Inc.QOC 5.5NYXHNyxoah SAQOC 5.6INBSIntelligent Bio Solutions Inc.QOC 5.4LMRILumexa Imaging Holdings, Inc.QOC 3.5TXG10x Genomics, Inc.QOC 7.6TNDMTandem Diabetes Care, Inc.QOC 6.5IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: NXL · LUCD · NNOX · GTHP · NYXH · INBS · LMRI · TXG · TNDM · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to PLSM?

6 companies across all industries closest to PLSM’s Quality of Company score of 5.6/10.

OPKOPKO Health, Inc.QOC 5.6APAmpco-Pittsburgh CorporationQOC 5.6LZMHLZ Technology Holdings LimitedQOC 5.6ASBPAspire Biopharma Holdings, Inc.QOC 5.6IVAInventiva S.A.QOC 5.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: OPK · AP · LZMH · ASBP · IVA · NVDA

Where Does PLSM Sit in CirclFi's Medical Devices Rankings?

PLSM is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Pulsenmore Ltd.’s Valuation?

What is Pulsenmore Ltd.'s intrinsic value in 2026?

CirclFi puts Pulsenmore Ltd. (PLSM)'s intrinsic value at $4.84 — the median of 2 independent model estimates as of 2026-10-07, ranging from $2.70 to $6.98. The Quality of Company score is 5.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PLSM overvalued or undervalued right now?

At $2.16, 2 of 2 active models suggest PLSM may be undervalued, while 0 indicate potential overvaluation. The median of all 2 fair value estimates is $4.84, 124.1% above the current price of $2.16 — a consensus view that PLSM is undervalued. The assessment depends on which methodology best fits Pulsenmore Ltd.'s business model in Medical Devices.

What does a Quality of Company score of 5.6 mean for PLSM?

Pulsenmore Ltd.'s QOC of 5.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on PLSM?

CirclFi analyzes PLSM with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is PLSM a value trap in 2026?

Pulsenmore Ltd.'s Value Trap score is 10/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Pulsenmore Ltd. (PLSM) has a median fair value of $4.84 — 124.1% above the current price of $2.16 — as of 2026-10-07.” Source: circlfi.com/stock/PLSM/ · Methodology
Primary sources for this PLSM valuation
  • Financial statements: Pulsenmore Ltd. 10-K and 10-Q filings on SEC EDGAR (CIK 0002064764) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for PLSM as of ; valuations recomputed .